Table 1.
Demographic and baseline values of outcome variables.
| Asthma, TCC | Asthma, no TCC | Control, TCC | Control, no TCC | p value | |
|---|---|---|---|---|---|
| (n = 20) | (n = 9) | (n = 18) | (n = 14) | ||
| Age, years (mean ± SD) | 10.55 ± 0.27 | 10.33 ± 0.53 | 10.11 ± 0.21 | 10.57 ± 0.17 | 0.47 |
| Males, n (%) | 12 (60) | 4 (44) | 7 (39) | 6 (43) | 0.58 |
| Females, n (%) | 8 (40) | 5 (56) | 11 (61) | 8 (57) | |
|
| |||||
| Anthropometric measurement | |||||
|
| |||||
| Height, cm (mean ± SD) | 130 ± 4.8 | 135 ± 2.58 | 142.3 ± 8.03 | 144.79 ± 7.44 | 0.68 |
| Weight, kg (mean ± SD) | 36 ± 9.27 | 38.6 ± 10.86 | 35.86 ± 6.22 | 38.36 ± 10.36 | 0.95 |
| BMI (mean ± SD) | 17.95 ± 3.4 | 21.12 ± 5.73 | 17.64 ± 2.49 | 18.1 ± 3.64 | 0.93 |
|
| |||||
| Pulmonary function | |||||
|
| |||||
| FVC (% of predicted) | 92.4 ± 14.9 | 96.81 ± 20.5 | 93.2 ± 14.8 | 90.6 ± 15.2 | 0.95 |
| FEV1 (% of predicted) | 89.2 ± 9.1 | 94.0 ± 17 | 92.7 ± 15.0 | 90.6 ± 15.1 | 0.86 |
| FEV1/FVC (%) | 91.3 ± 7.9 | 91.1 ± 6.7 | 93.3 ± 6.4 | 93.4 ± 7.6 | 0.65 |
| PEFR (L/min) | 194.1 ± 59.6 | 186.3 ± 35.0 | 197.7 ± 44.7 | 189.1 ± 44.3 | 0.97 |
| FeNO | 57.4 ± 30.7 | 39.2 ± 14.9 | 40.2 ± 25.1 | 26.6 ± 17.4 | 0.02 |
|
| |||||
| Pediatric Asthma Quality of Life Questionnaire (PAQLQ) | |||||
| (n = 18) | (n = 5) | ||||
|
| |||||
| Total score | 137.2 ± 24.01 | 151 ± 7.61 | 0.28 | ||
| Symptom score | 56.44 ± 15.18 | 65.6 ± 3.65 | 0.18 | ||
| Activity limitation score | 29.78 ± 4.29 | 31.4 ± 3.36 | 0.52 | ||
| Emotional function score | 51.06 ± 6.12 | 54 ± 2.92 | 0.30 | ||
BMI, body mass index; FEV1, forced expiratory volume in 1 second; FVC, forced vital capacity; PEFR, peak expiratory flow rate; FeNO, fractional exhaled nitric oxide. p value was obtained by Kruskal-Wallis test or Mann–Whitney U test or depending on the type of variables. All values are expressed as mean ± SD.